Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.
PARD stock price ended at $0 on lunes, after rising NaN%
On the latest trading day Dec 15, 2025, the stock price of PARD rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 54 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 196 shares were traded, equating to a market value of approximately --.
Señales Técnicas de PARD
Resumen de Señales Técnicas
Señales de compra 0
Señales Neutras 6
Señales de venta 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
PARD actualmente presenta 0 señales de compra y 1 señales de venta. La acción ha estado en una tendencia alcista desde 12:00 AM, con un cambio total en el precio de -- durante este período. En general, los indicadores técnicos apuntan a una perspectiva Sell para el mediano plazo.
Señales alcistas/bajistas para PARD
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para PARD. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.
Preguntas de seguimiento
¿Cómo se aplican los indicadores de análisis técnico a PARD?
¿Cuál es el RSI de Poniard Pharmaceuticals Inc?
¿Cuál es el precio de Poniard Pharmaceuticals Inc para los próximos 12 meses?
¿Hasta dónde se espera que suba Poniard Pharmaceuticals Inc?